FDA Approves Immunotherapy Combo for Stage 3 Colon Cancer After Surgery
The U.S. Food and Drug Administration has approved atezolizumab combined with chemotherapy for certain stage 3 colon cancer patients following surgical removal of tumors. This approval applies…